Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS

Nature Reviews Neurology

Volumn 8, Issue 2, 2012, Pages 86-96

  Rajakulendran, Sanjeev ^a   Kaski, Diego ^b   Hanna, Michael G ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; ACETAZOLAMIDE; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL P TYPE;

CACNA1A GENE; CLINICAL FEATURE; DISEASE ASSOCIATION; EPILEPSY; EPISODIC ATAXIA TYPE 2; FAMILIAL HEMIPLEGIC MIGRAINE; GENETIC ASSOCIATION; HEREDITARY ATAXIA; HUMAN; MIGRAINE; MUTATOR GENE; NEURONAL CHANNELOPATHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SPINOCEREBELLAR DEGENERATION;

ANIMALS; CALCIUM CHANNELS, N-TYPE; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MUTATION; NEURONS;

EID: 84857044266     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.228     Document Type: Review

References (149)

1. 1A subunits of brain calcium channels. J. Neurosci. 15, 6403-6418 (1995).
2. 2+ channel subunits. Genomics 30, 605-609 (1995). (Pubitemid 26038558)
3. Jodice, C. et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum. Mol. Genet. 6, 1973-1978 (1997). (Pubitemid 27460375)
4. McKusick-Nathans Institute of Genetic Medicine, John Hopkins University School of Medicine. OMIM-Online Mendelian Inheritance in Man [online] http://www.ncbi.nlm.nih.gov/omim 2011).
5. Jouvenceau, A. et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358, 801-807 (2001). (Pubitemid 32868732)
6. V2.1 in absence epilepsy and episodic ataxia. Brain 127, 2682-2692 (2004). (Pubitemid 39627377)
7. Rajakulendran, S. et al. Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy. J. Physiol. 588, 1905-1913 (2010).
8. Vincent, A. Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems. J. Clin. Immunol. 30 (Suppl. 1), S97-S102 (2010).
9. Farrugia, M. E. & Vincent, A. Autoimmune mediated neuromuscular junction defects. Curr. Opin. Neurol. 23, 489-495 (2010).
10. Graus, F. et al. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59, 764-766 (2002).
11. Spillane, J., Beeson, D. J. & Kullmann, D. M. Myasthenia and related disorders of the neuromuscular junction. J. Neurol. Neurosurg. Psychiatry 81, 850-857 (2010).
12. 2+ channels. Nature 366, 158-161 (1993). (Pubitemid 23351820)
13. 2+/calmodulin complex. Nat. Struct. Mol. Biol. 12, 1108-1115 (2005). (Pubitemid 41746782)
14. Mochida, S. et al. Requirement for the synaptic protein interaction site for reconstitution of synaptic transmission by P/Q-type calcium channels. Proc. Natl Acad. Sci. USA 100, 2819-2824 (2003). (Pubitemid 36297582)
15. 2+ channels with the presynaptic proteins syntaxin and SNAP-25. Proc. Natl Acad. Sci. USA 93, 7363-7368 (1996)
16. 2+ channels and SNARE proteins in neurotransmitter release. Ann. N. Y. Acad. Sci. 868, 144-159 (1999). (Pubitemid 29281123)
17. Mochida, S., Westenbroek, R. E., Yokoyama, C. T., Itoh, K. & Catterall, W. A. Subtype-selective reconstitution of synaptic transmission in sympathetic ganglion neurons by expression of exogenous calcium channels. Proc. Natl Acad. Sci. USA 100, 2813-2818 (2003) (Pubitemid 36297581)
18. 2+ channels. Annu. Rev. Cell Dev. Biol. 16, 521-555 (2000). (Pubitemid 32037516)
19. Catterall, W. A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13-25 (2000).
20. Jorntell, H. & Hansel, C. Synaptic memories upside down: bidirectional plasticity at cerebella parallel fiber-Purkinje cell synapses. Neuron 52, 227-238 (2006). (Pubitemid 44548347)
21. Higley, M. J. & Sabatini, B. L. Calcium signaling in dendrites and spines: practical and functional considerations. Neuron 59, 902-913 (2008).
22. Kongsamut, S., Lipscombe, D. & Tsien, R. W. The N-type Ca channel in frog sympathetic neurons and its role in α-adrenergic modulation of transmitter release. Ann. N. Y. Acad. Sci. 560, 312-333 (1989). (Pubitemid 19226240)
23. 1A subunit gene generates phenotypic variants of P-and Q-type calcium channels. Nat. Neurosci. 2, 407-415 (1999). (Pubitemid 30491249)
24. 2+ current. J. Biol. Chem. 277, 7214-7221 (2002). (Pubitemid 34953113)
25. 2+-dependent inactivation. J. Neurosci. 22, 10142-10152 (2002). (Pubitemid 35416853)
26. V2.1 cause episodic ataxia type 2. Neurobiol. Dis. 32, 10-15 (2008).
27. 1A- voltage-dependent calcium channel. Nat. Genet. 15, 62-69 (1997).
28. 1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet. 8, 1185-1193 (1999). (Pubitemid 29328986)
29. Romaniello, R. et al. A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J. Neurol. Neurosurg. Psychiatry 81, 840-843 (2010).
30. Parker, H. L. Periodic ataxia. Collect. Papers Mayo Clinic Mayo Found. 38, 642-645 (1946-1947).
31. 2+ channel gene CACNL1A4. Cell 87, 543-552 (1996). (Pubitemid 26374327)
32. Jen, J. C. et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 130, 2484-2493 (2007). (Pubitemid 47511698)
33. Jen, J., Kim, G. W. & Baloh, R. W. Clinical spectrum of episodic ataxia type 2. Neurology 62, 17-22 (2004). (Pubitemid 38082863)
34. Baloh, R. W., Yue, Q., Furman, J. M. & Nelson, S. F. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann. Neurol. 41, 8-16 (1997). (Pubitemid 27057087)
35. Riant, F., Mourtada, R., Saugier-Veber, P. & Tournier-Lasserve, E. Large CACNA1A deletion in a family with episodic ataxia type 2. Arch. Neurol. 65, 817-820 (2008). (Pubitemid 351831462)
36. Imbrici, P. et al. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 65, 944-946 (2005). (Pubitemid 41362150)
37. Engel, K. C., Anderson, J. H., Gomez, C. M. & Soechting, J. F. Deficits in ocular and manual tracking due to episodic ataxia type 2. Mov. Disord. 19, 778-787 (2004). (Pubitemid 39139588)
38. Sasaki, O. et al. Neurotological findings in a family with episodic ataxia. J. Neurol. 250, 373-375 (2003). (Pubitemid 36399286)
39. Jen, J. et al. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57, 1843-1848 (2001). (Pubitemid 33096693)
40. V2.1 single amino acid substitution R2090Q. J. Neurol. Sci. 296, 104-106 (2010).
41. Spacey, S. D., Materek, L. A., Szczygielski, B. I. & Bird, T. D. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch. Neurol. 62, 314-316 (2005). (Pubitemid 40204755)
42. Roubertie, A. et al. Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family. J. Neurol. 255, 1600-1602 (2008).
43. Eunson, L. H., Graves, T. D. & Hanna, M. G. New calcium channel mutations predict aberrant RNA splicing in episodic ataxia. Neurology 65, 308-310 (2005). (Pubitemid 41022382)
44. Mochizuki, Y. et al. Hereditary paroxysmal ataxia with mental retardation: a clinicopathological study in relation to episodic ataxia type 2. Acta Neuropathol. 108, 345-349 (2004). (Pubitemid 39317703)
45. Vighetto, A., Froment, J. C., Trillet, M. & Aimard, G. Magnetic resonance imaging in familial paroxysmal ataxia. Arch. Neurol. 45, 547-549 (1988).
46. Hawkes, C. H. Familial paroxysmal ataxia: report of a family. J. Neurol. Neurosurg. Psychiatry 55, 212-213 (1992).
47. Bain, P. G., O'Brien, M. D., Keevil, S. F. & Porter, D. A. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann. Neurol. 31, 147-154 (1992).
48. 1H MRS study. Neurology 64, 542-544 (2005). (Pubitemid 40189879)
49. Vahedi, K. et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann. Neurol. 37, 289-293 (1995).
50. Kramer, P. L. et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am. J. Hum. Genet. 57, 182-185 (1995).
51. von Brederlow, B., Hahn, A. F., Koopman, W. J., Ebers, G. C. & Bulman, D. E. Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum. Mol. Genet. 4, 279-284 (1995).
52. V2.1 causing episodic ataxia 2. J. Med. Genet. 41, e82 (2004).
53. Jen, J. C. & Baloh, R. W. Genetics of episodic ataxia. Adv. Neurol. 89, 459-461 (2002).
54. Guida, S. et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68, 759-764 (2001). (Pubitemid 32202768)
55. Strupp, M., Zwergal, A. & Brandt, T. Episodic ataxia type 2. Neurotherapeutics 4, 267-273 (2007). (Pubitemid 46467550)
56. Wan, J., Carr, J. R., Baloh, R. W. & Jen, J. C. Nonconsensus intronic mutations cause episodic ataxia. Ann. Neurol. 57, 131-135 (2005). (Pubitemid 40053325)
57. Labrum, R. W. et al. Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing. J. Med. Genet. 46, 786-791 (2009).
58. Riant, F. et al. Identification of CACNA1A large deletions in four patients with episodic ataxia. Neurogenetics 11, 101-106 (2010).
59. Veneziano, L. et al. Newly characterised 5' and 3' regions of CACNA1A gene harbour mutations associated with familial hemiplegic migraine and episodic ataxia. J. Neurol. Sci. 276, 31-37 (2009).
60. Mantuano, E. et al. Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J. Neurol. Sci. 291, 30-36 (2010).
61. V2 calcium channels: implications for episodic ataxia type 2. J. Biol. Chem. 285, 835-844 (2010).
62. 2+ channels. J. Cell. Physiol. 214, 422-433 (2008).
63. 12.1 truncations requires the conserved interaction domain for β subunits. Mol. Cell. Neurosci. 34, 168-177 (2007). (Pubitemid 46136993)
64. Page, K. M. et al. Dominant-negative calcium channel suppression by truncated constructs involves a kinase implicated in the unfolded protein response. J. Neurosci. 24, 5400-5409 (2004). (Pubitemid 38747682)
65. Mezghrani, A. et al. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. J. Neurosci. 28, 4501-4511 (2008).
66. 2+ channelopathy. Neuron 43, 387-400 (2004).
67. Maselli, R. A. et al. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 61, 1743-1748 (2003). (Pubitemid 38020822)
68. Walter, J. T., Alviña, K., Womack, M. D., Chevez, C. & Khodakhah, K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat. Neurosci. 9, 389-397 (2006). (Pubitemid 43290969)
69. Pietrobon, D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr. Opin. Neurobiol. 15, 257-265 (2005). (Pubitemid 40806436)
70. Seemungal, B. M., Gresty, M. A. & Bronstein, A. M. The endocrine system, vertigo and balance. Curr. Opin. Neurol. 14, 27-34 (2001). (Pubitemid 32116254)
71. Helmich, R. C. et al. The dynamic regulation of cortical excitability is altered in episodic ataxia type 2. Brain 133, 3519-3529 (2010).
72. Harno, H. et al. Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2). J. Neurol. 251, 232-234 (2004). (Pubitemid 38221642)
73. Griggs, R. C., Moxley, R. T. 3rd, Lafrance, R. A. & McQuillen, J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 28, 1259-1264 (1978). (Pubitemid 9030411)
74. Calandriello, L. et al. Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13. Brain 120, 805-812 (1997). (Pubitemid 27222985)
75. Spacey, S. D., Hildebrand, M. E., Materek, L. A., Bird, T. D. & Snutch, T. P. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann. Neurol. 56, 213-220 (2004). (Pubitemid 39043666)
76. Strupp, M. et al. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 62, 1623-1625 (2004). (Pubitemid 38608211)
77. Strupp, M. et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77, 269-275 (2011).
78. Dieterich, M. & Brandt, T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J. Neurol. 246, 883-892 (1999). (Pubitemid 29512157)
79. Furman, J. M., Marcus, D. A. & Balaban, C. D. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr. Opin. Neurol. 16, 5-13 (2003). (Pubitemid 36206757)
80. Neuhauser, H., Leopold, M., von Brevern, M., Arnold, G. & Lempert, T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56, 436-441 (2001). (Pubitemid 32172864)
81. Murdin, L., Davies, R. A. & Bronstein, A. M. Vertigo as a migraine trigger. Neurology 73, 638-642 (2009).
82. Browne, D. L. et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 8, 136-140 (1994). (Pubitemid 24308360)
83. Litt, M. et al. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am. J. Hum. Genet. 55, 702-709 (1994). (Pubitemid 24298969)
84. Eunson, L. H. et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann. Neurol. 48, 647-656 (2000).
85. Rajakulendran, S., Schorge, S., Kullmann, D. M. & Hanna, M. G. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics 4, 258-266 (2007). (Pubitemid 46467545)
86. Escayg, A. et al. Coding and noncoding variation of the human calcium-channel β4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am. J. Hum. Genet. 66, 1531-1539 (2000). (Pubitemid 30463072)
87. Graves, T. D. & Hanna, M. G. Episodic ataxia: SLC1A3 and CACNB4 do not explain the apparent genetic heterogeneity. J. Neurol. 255, 1097-1099 (2008).
88. Cader, M. Z., Steckley, J. L., Dyment, D. A., McLachlan, R. S. & Ebers, G. C. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 65, 156-158 (2005). (Pubitemid 40967797)
89. Farmer, T. W. & Mustian, V. M. Familial periodic vertigo, diplopia, and ataxia. Trans. Am. Neurol. Assoc. 87, 86-90 (1962).
90. Damji, K. F. et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch. Neurol. 53, 338-344 (1996). (Pubitemid 26110089)
91. Meisler, M. H., Kearney, J., Escayg, A., MacDonald, B. T. & Sprunger, L. K. Sodium channels and neurological disease: insights from Scn8a mutations in the mouse. Neuroscientist 7, 136-145 (2001). (Pubitemid 32245019)
92. Jen, J. C., Wan, J., Palos, T. P., Howard, B. D. & Baloh, R. W. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65, 529-534 (2005). (Pubitemid 41170710)
93. de Vries, B. et al. Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. Arch. Neurol. 66, 97-101 (2009).
94. Kerber, K. A., Jen, J. C., Lee, H., Nelson, S. F. & Baloh, R. W. A new episodic ataxia syndrome with linkage to chromosome 19q13. Arch. Neurol. 64, 749-752 (2007). (Pubitemid 46789844)
95. Cha, Y. H. et al. Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q. J. Neurol. Neurosurg. Psychiatry 78, 1273-1275 (2007).
96. Ducros, A. et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 345, 17-24 (2001). (Pubitemid 32634267)
97. Thomsen, L. L., Olesen, J. & Russell, M. B. Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur. J. Neurol. 10, 421-427 (2003). (Pubitemid 41754763)
98. Ducros, A. et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann. Neurol. 42, 885-890 (1997). (Pubitemid 28008419)
99. Pietrobon, D. Familial hemiplegic migraine. Neurotherapeutics 4, 274-284 (2007). (Pubitemid 46467543)
100. Kors, E. E. et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol. 49, 753-760 (2001). (Pubitemid 32530242)
101. + pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192-196 (2003). (Pubitemid 36177073)
102. Riant, F. et al. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum. Mutat. 26, 281 (2005).
103. Dichgans, M. et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366, 371-377 (2005). (Pubitemid 41073954)
104. V2.1 current density in neurons. Proc. Natl Acad. Sci. USA 99, 13284-13289 (2002).
105. 1A calcium channel subunit linked to familial hemiplegic migraine. J. Neurosci. 19, 1610-1619 (1999). (Pubitemid 29094180)
106. van den Maagdenberg, A. M. et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41, 701-710 (2004). (Pubitemid 38326833)
107. Omata, T., Takanashi, J., Wada, T., Arai, H. & Tanabe, Y. Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine. Brain Dev. 33, 332-334 (2011).
108. Battistini, S. et al. A new CACNA1A gene mutation in acetazolamide- responsive familial hemiplegic migraine and ataxia. Neurology 53, 38-43 (1999). (Pubitemid 29329646)
109. Jen, J. C. Familial hemiplegic migraine. GeneReviews, NCBI Bookshelf, US National Library of Medicine, NIH [online], Error! Hyperlink reference not valid.(2009).
110. Yu-Wai-Man, P., Gorman, G., Bateman, D. E., Leigh, R. J. & Chinnery, P. F. Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6. J. Neurol. 256, 78-82 (2009).
111. Craig, K., Keers, S. M., Archibald, K., Curtis, A. & Chinnery, P. F. Molecular epidemiology of spinocerebellar ataxia type 6. Ann. Neurol. 55, 752-755 (2004). (Pubitemid 38544340)
112. Gomez, C. M. et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann. Neurol. 42, 933-950 (1997). (Pubitemid 28008425)
113. Hashimoto, T., Sasaki, O., Yoshida, K., Takei, Y. & Ikeda, S. Periodic alternating nystagmus and rebound nystagmus in spinocerebellar ataxia type 6. Mov. Disord. 18, 1201-1204 (2003). (Pubitemid 37336950)
114. 2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J. Neurosci. 19, RC14 (1999).
115. 2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6. J. Neurosci. 21, 9185-9193 (2001). (Pubitemid 33096862)
116. Restituito, S. et al. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a β subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. J. Neurosci. 20, 6394-6403 (2000).
117. V2.1 channels. Proc. Natl Acad. Sci. USA 105, 11987-11992 (2008).
118. Liu, J. et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J. Neurosci. 29, 9148-9162 (2009).
119. Schorge, S., van de Leemput, J., Singleton, A., Houlden, H. & Hardy, J. Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signalling. Trends Neurosci. 33, 211-219 (2010).
120. Khosravani, H. & Zamponi, G. W. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol. Rev. 86, 941-966 (2006). (Pubitemid 44033386)
121. V2.1 calcium channel neuropathologies. Neuroscience 155, 31-44 (2008).
122. Zwingman, T. A., Neumann, P. E., Noebels, J. L. & Herrup, K. Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a. J. Neurosci. 21, 1169-1178 (2001). (Pubitemid 32128762)
123. Noebels, J. L. & Sidman, R. L. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 204, 1334-1336 (1979). (Pubitemid 9180470)
124. Fletcher, C. F. et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87, 607-617 (1996). (Pubitemid 26386935)
125. Fletcher, C. F. & Frankel, W. N. Ataxic mouse mutants and molecular mechanisms of absence epilepsy. Hum. Mol. Genet. 8, 1907-1912 (1999). (Pubitemid 29458669)
126. Lorenzon, N. M., Lutz, C. M., Frankel, W. N. & Beam, K. G. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner. J. Neurosci. 18, 4482-4489 (1998). (Pubitemid 28280159)
127. Neufeld, M. Y., Nisipeanu, P., Chistik, V. & Korczyn, A. D. The electroencephalogram in acetazolamide-responsive periodic ataxia. Mov. Disord. 11, 283-288 (1996). (Pubitemid 26138827)
128. Van Bogaert, P. & Szliwowski, H. B. EEG findings in acetazolamide-responsive hereditary paroxysmal ataxia. Neurophysiol. Clin. 26, 335-340 (1996). (Pubitemid 26412611)
129. Beauvais, K. et al. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur. Neurol. 52, 58-61 (2004). (Pubitemid 39077818)
130. Kors, E. E. et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63, 1136-1137 (2004). (Pubitemid 39287940)
131. Gourfinkel-An, I. et al. Monogenic idiopathic epilepsies. Lancet Neurol. 3, 209-218 (2004). (Pubitemid 38373659)
132. 1A calcium channel gene CACNA1A and idiopathic generalized epilepsy. Neurology 56, 1245-1246 (2001). (Pubitemid 32405731)
133. Cavalleri, G. L. et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol. 6, 970-980 (2007). (Pubitemid 47570022)
134. 1A calcium channel gene and common syndromes of idiopathic generalized epilepsy. Epilepsy Res. 49, 173-177 (2002). (Pubitemid 34607365)
135. Helbig, I., Scheffer, I. E., Mulley, J. C. & Berkovic, S. F. Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol. 7, 231-245 (2008). (Pubitemid 351215982)
136. Lapie, P., Goudet, C., Nargeot, J., Fontaine, B. & Lory, P. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle α 1s subunit as expressed in mouse L cells. FEBS Lett. 382, 244-248 (1996).
137. 2+ channel expressed in Xenopus laevis oocytes. J. Physiol. 520, 321-336 (1999). (Pubitemid 29511898)
138. Jurkat-Rott, K., McCarthy, T. & Lehmann-Horn, F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23, 4-17 (2000).
139. V1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31 (2004). (Pubitemid 39349317)
140. Splawski, I. et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl Acad. Sci. USA 102, 8089-8096 (2005). (Pubitemid 40800048)
141. V1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency. Pflugers Arch. 460, 353-359 (2010).
142. 2+ channels. Pflugers Arch. 460, 361-374 (2010).
143. Strom, T. M. et al. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat. Genet. 19, 260-263 (1998). (Pubitemid 28309338)
144. McRory, J. E. et al. The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution. J. Neurosci. 24, 1707-1718 (2004). (Pubitemid 38240968)
145. 2+ channels-integration centers for neuronal signaling pathways. Trends Neurosci. 29, 617-624 (2006). (Pubitemid 44602257)
146. Perez-Reyes, E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 83, 117-161 (2003). (Pubitemid 36459879)
147. Perez-Reyes, E. Molecular characterization of T-type calcium channels. Cell Calcium 40, 89-96 (2006). (Pubitemid 43942294)
148. Iftinca, M. C. & Zamponi, G. W. Regulation of neuronal T-type calcium channels. Trends Pharmacol. Sci. 30, 32-40 (2009).
149. Zamponi, G. W., Lory, P. & Perez-Reyes, E. Role of voltage-gated calcium channels in epilepsy. Pflugers Arch. 460, 395-403 (2010).